Chitosan nanoparticles show rapid extrapulmonary tissue distribution and excretion with mild pulmonary inflammation to micen

Mina Choi, Minjung Cho, Beom Seok Han, Jin Hong, Jayoung Jeong, Sangjin Park, Myung Haing Cho, Kwang Meyung Kim, Wan Seob Cho

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Pulmonary delivery of nanoparticles (NP) conjugated with therapeutic agents has been considered recently for both lung disorders and systemic circulation. Hydrophobically modified glycol chitosan (HGC) NP have previously shown excellent deposition to the tumor site and non-destructive intracellular release. Here, we evaluated the kinetics and toxicity of HGC NP by intratracheal instillation to mice. HGC NP showed a positive charge and average hydrodynamic size was around 350. nm. The half-life of NP in the lung was determined as 131.97 ± 50.51. h. NP showed rapid uptake into systemic circulation and excretion via urine which was peaked at 6. h after instillation. Although HGC NP were distributed to several extrapulmonary organs, the levels were extremely low and transient. HGC NP induced transient neutrophilic pulmonary inflammation from 6. h to day 3 after instillation. Expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) and chemokine (MIP-1α) in lung showed an increase from 1. h to 24. h after instillation and recovered thereafter. Our findings suggest that HGC NP can be successful candidates for use as pulmonary delivery vehicles, owing to their excellent biocompatibility, transiency, and low pulmonary toxicity, and property of rapid elimination without accumulation.

Original languageEnglish
Pages (from-to)144-152
Number of pages9
JournalToxicology Letters
Volume199
Issue number2
DOIs
Publication statusPublished - 2010 Nov 30
Externally publishedYes

Fingerprint

Chitosan
Tissue Distribution
Nanoparticles
Pneumonia
Tissue
Lung
Toxicity
Hydrodynamics
Interleukin-1
Biocompatibility
Chemokines
Half-Life
glycol-chitosan
Tumors
Interleukin-6
Urine
Cytokines
Kinetics

Keywords

  • Elimination
  • Hydrophobically modified glycol chitosan
  • Intratracheal instillation
  • Pulmonary delivery vehicle
  • Tissue distribution

ASJC Scopus subject areas

  • Toxicology

Cite this

Chitosan nanoparticles show rapid extrapulmonary tissue distribution and excretion with mild pulmonary inflammation to micen. / Choi, Mina; Cho, Minjung; Han, Beom Seok; Hong, Jin; Jeong, Jayoung; Park, Sangjin; Cho, Myung Haing; Kim, Kwang Meyung; Cho, Wan Seob.

In: Toxicology Letters, Vol. 199, No. 2, 30.11.2010, p. 144-152.

Research output: Contribution to journalArticle

Choi, Mina ; Cho, Minjung ; Han, Beom Seok ; Hong, Jin ; Jeong, Jayoung ; Park, Sangjin ; Cho, Myung Haing ; Kim, Kwang Meyung ; Cho, Wan Seob. / Chitosan nanoparticles show rapid extrapulmonary tissue distribution and excretion with mild pulmonary inflammation to micen. In: Toxicology Letters. 2010 ; Vol. 199, No. 2. pp. 144-152.
@article{0a06be1b21024a9eb9ec072fb3e44421,
title = "Chitosan nanoparticles show rapid extrapulmonary tissue distribution and excretion with mild pulmonary inflammation to micen",
abstract = "Pulmonary delivery of nanoparticles (NP) conjugated with therapeutic agents has been considered recently for both lung disorders and systemic circulation. Hydrophobically modified glycol chitosan (HGC) NP have previously shown excellent deposition to the tumor site and non-destructive intracellular release. Here, we evaluated the kinetics and toxicity of HGC NP by intratracheal instillation to mice. HGC NP showed a positive charge and average hydrodynamic size was around 350. nm. The half-life of NP in the lung was determined as 131.97 ± 50.51. h. NP showed rapid uptake into systemic circulation and excretion via urine which was peaked at 6. h after instillation. Although HGC NP were distributed to several extrapulmonary organs, the levels were extremely low and transient. HGC NP induced transient neutrophilic pulmonary inflammation from 6. h to day 3 after instillation. Expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) and chemokine (MIP-1α) in lung showed an increase from 1. h to 24. h after instillation and recovered thereafter. Our findings suggest that HGC NP can be successful candidates for use as pulmonary delivery vehicles, owing to their excellent biocompatibility, transiency, and low pulmonary toxicity, and property of rapid elimination without accumulation.",
keywords = "Elimination, Hydrophobically modified glycol chitosan, Intratracheal instillation, Pulmonary delivery vehicle, Tissue distribution",
author = "Mina Choi and Minjung Cho and Han, {Beom Seok} and Jin Hong and Jayoung Jeong and Sangjin Park and Cho, {Myung Haing} and Kim, {Kwang Meyung} and Cho, {Wan Seob}",
year = "2010",
month = "11",
day = "30",
doi = "10.1016/j.toxlet.2010.08.016",
language = "English",
volume = "199",
pages = "144--152",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Chitosan nanoparticles show rapid extrapulmonary tissue distribution and excretion with mild pulmonary inflammation to micen

AU - Choi, Mina

AU - Cho, Minjung

AU - Han, Beom Seok

AU - Hong, Jin

AU - Jeong, Jayoung

AU - Park, Sangjin

AU - Cho, Myung Haing

AU - Kim, Kwang Meyung

AU - Cho, Wan Seob

PY - 2010/11/30

Y1 - 2010/11/30

N2 - Pulmonary delivery of nanoparticles (NP) conjugated with therapeutic agents has been considered recently for both lung disorders and systemic circulation. Hydrophobically modified glycol chitosan (HGC) NP have previously shown excellent deposition to the tumor site and non-destructive intracellular release. Here, we evaluated the kinetics and toxicity of HGC NP by intratracheal instillation to mice. HGC NP showed a positive charge and average hydrodynamic size was around 350. nm. The half-life of NP in the lung was determined as 131.97 ± 50.51. h. NP showed rapid uptake into systemic circulation and excretion via urine which was peaked at 6. h after instillation. Although HGC NP were distributed to several extrapulmonary organs, the levels were extremely low and transient. HGC NP induced transient neutrophilic pulmonary inflammation from 6. h to day 3 after instillation. Expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) and chemokine (MIP-1α) in lung showed an increase from 1. h to 24. h after instillation and recovered thereafter. Our findings suggest that HGC NP can be successful candidates for use as pulmonary delivery vehicles, owing to their excellent biocompatibility, transiency, and low pulmonary toxicity, and property of rapid elimination without accumulation.

AB - Pulmonary delivery of nanoparticles (NP) conjugated with therapeutic agents has been considered recently for both lung disorders and systemic circulation. Hydrophobically modified glycol chitosan (HGC) NP have previously shown excellent deposition to the tumor site and non-destructive intracellular release. Here, we evaluated the kinetics and toxicity of HGC NP by intratracheal instillation to mice. HGC NP showed a positive charge and average hydrodynamic size was around 350. nm. The half-life of NP in the lung was determined as 131.97 ± 50.51. h. NP showed rapid uptake into systemic circulation and excretion via urine which was peaked at 6. h after instillation. Although HGC NP were distributed to several extrapulmonary organs, the levels were extremely low and transient. HGC NP induced transient neutrophilic pulmonary inflammation from 6. h to day 3 after instillation. Expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) and chemokine (MIP-1α) in lung showed an increase from 1. h to 24. h after instillation and recovered thereafter. Our findings suggest that HGC NP can be successful candidates for use as pulmonary delivery vehicles, owing to their excellent biocompatibility, transiency, and low pulmonary toxicity, and property of rapid elimination without accumulation.

KW - Elimination

KW - Hydrophobically modified glycol chitosan

KW - Intratracheal instillation

KW - Pulmonary delivery vehicle

KW - Tissue distribution

UR - http://www.scopus.com/inward/record.url?scp=77957951953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957951953&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2010.08.016

DO - 10.1016/j.toxlet.2010.08.016

M3 - Article

VL - 199

SP - 144

EP - 152

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 2

ER -